An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population

Annals of Saudi Medicine

Volumn 32, Issue 6, 2012, Pages 637-641

  Sadat Ali, Mir ^a   Al Habdan, Ibrahim M ^a   Al Turki, Haifa A ^a   Azam, Mohammed Quamar ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BONE DENSITY; BONE MASS; BONE STRUCTURE; DENSITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EARLY DIAGNOSIS; FEMUR FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MORBIDITY; OSTEOPENIA; OSTEOPOROSIS; PRIMARY OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SAUDI ARABIA; SECONDARY OSTEOPOROSIS; SENSITIVITY AND SPECIFICITY; SPINE FRACTURE; SYSTEMATIC REVIEW; VERTEBRA MALFORMATION;

INCIDENCE; MASS SCREENING; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; RISK ASSESSMENT; SAUDI ARABIA;

EID: 84873903250     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2012.637     Document Type: Review

References (53)

1. Melton LJ, 3rd How many women have osteoporosis now? J Bone Miner Res 1995; 10:175.
2. Lindsay R. Osteoporosis: a guide to diagnosis, prevention, and treatment. New York: Raven Press, 1992.
3. Sadat-Ali M, El-Hassan AY, Ezzeldin IM et al : Postmenopausal osteoporosis in Saudi Women : A pilot screening. Annals of Saudi Med 1993;. 13: 272-74.
4. Sadat-Al M, Al-Habdan I, Marwah S. Bone Mineral Density measurements of distal radius in Saudi Arabian females. Annals of Saudi Med 1996, 16(4): 414-16.
5. Al-Habdan IM, Sadat-Ali M, Al-Muhanna FA, Al- Elq AH, Al-Mulhim AA. Bone mass measurement using quantitative ultrasound in healthy Saudi women. A cross-sectional screening. Saudi Med J. 2009 Nov;30(11):1426-31.
6. El-Desouki MI. Osteoporosis in postmenopausal Saudi women using dual x-ray bone densitometry. Saudi Med J. 2003 Sep;24(9):953-56.
7. Ardawi MS, Maimany AA, Bahksh TM, Nasrat HA, Milaat WA, Al-Raddadi RM. Bone mineral density of the spine and femur in healthy Saudis. Osteoporos Int. 2005 Jan;16(1):43-55.
8. Sadat-Ali M, Al-Habdan I, Al-Mulhim AA, Yousef A. Effect of parity on Bone mineral density in Postmenopausal Saudi women. Saudi Med J 2005;26(10):1588-90.
9. Sadat-Ali Sadat-Ali M, Al-Habdan I, Al-Mulhim Fatma, Yousef A. Bone Mineral density among postmenopausal Saudi Arabian women. Saudi Med J 2004; 25(11):1623-25.
10. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Verte- bral Efficacy With Risedronate Therapy (VERT ) Study Group. JAMA. 1999; 282:1344-52. [PMID: 10527181].
11. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535-41. [PMID: 8950879].
12. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333-40. [PMID: 11172164].
13. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE ) Investigators. JAMA. 1999;282:637-45. [PMID: 10517716].
14. Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002;87:3609-17. [PMID: 12161484].
15. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-41. [PMID: 11346808].
16. Stafford RS, Drieling RL, Hersh AL. National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. Arch Intern Med. 2004;164:1525-30. [PMID: 15277283].
17. Freedman KB, Kaplan FS, Bilker WB, et al. (2000) Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am 82-A:1063.
18. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001; 286:2815.
19. Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 2004;180:S18.
20. U.S. Preventive Services Task Force. Screening for osteoporosis in post- menopausal women: recommendations and rationale. Ann Intern Med. 2002; 137:526-8. [PMID: 12230355].
21. J. A. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Osteoporos Int 2008; DOI 10.1007/s00198-008-0560-z.
22. El-Desouki M. Osteoporosis In Postmenopausal Saudi Women Using Dual X-Ray Bone Densitometry. Saudi Medical Journal 1999;Vol. 20 (4):283-286.
23. El-Desouki MI, Sulimani RA. High prevalence of osteoporosis in Saudi men. Saudi Med J. 2007 May;28(5):774-7.
24. Sadat-Ali M, AlElq A.Osteoporosis among male Saudi Arabs: a pilot study. Ann Saudi Med. 2006 Nov-Dec;26(6):450-4.
25. Sadat-Ali M, Al-Elq A, Al-Turki H, Sultan O, Al- Ali A, AlMulhim F. Vitamin D level among patients with sickle cell anemia and its influence on bone mass. Am J Hematol. 2011 Jun;86(6):506-7. doi: 10.1002/ajh.22010. Epub 2011 Apr 20.
26. Al-Turki H. Influence of pregnancy on bone mass in sickle cell anemia. West Afr J Med. 2009 May;28(3):169-72.
27. Al Amri A, Sadat-Ali M. Cancer chemotherapyinduced osteoporosis: How common is it among Saudi Arabian cancer survivors. Indian J Cancer. 2009 Oct-Dec;46(4):331-4.
28. Sadat-Ali M, Al-Elq AH, Sultan O, Al-Turki H, Bukhari R, Al-Mulhim E.Low bone mass due to sickle cell anemia: is it becoming a real issue? West Afr J Med. 2008 Oct;27(4):218-23.
29. Sadat-Ali M, Alelq AH, Alshafei BA, Al-Turki HA, Abujubara MA.Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy. Ann Saudi Med. 2009 May-Jun;29(3):215-8.
30. Sadat-Ali M, Al-Othman A, Bubshait D, Al-Dakheel D.Does scoliosis causes low bone mass? A comparative study between siblings.Eur Spine J. 2008 Jul;17(7):944-7. Epub 2008 Apr 2.
31. Sadat-Ali M, Al Elq AH. Sickle cell anaemia: is it a cause for secondary osteoporosis? West Afr J Med. 2007 Apr-Jun;26(2):134-7.
32. Al-Elq AH, Sadat-Ali M. Diabetes mellitus and male osteoporosis. Is there a relationship? Saudi Med J. 2006 Nov;27(11):1729-33.
33. Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus. Saudi Med J. 2004 Oct;25(10):1423-7.
34. Sadat-Ali M, Gullenpet AH, Al-Turki HA, Abdulrahman TW, Al-Elq AH, Azzam MQ et al. Are we missing osteoporosis-related vertebral fractures in men?Asian Spine J. 2011 Jun;5(2):107-10.
35. Al-Osail AM, Sadat-Ali M, Al-Elq AH, Al-Omran AS, Azzam Q Glucocorticoid-related osteoporotic fractures. Singapore Med J. 2010 Dec;51(12):948-5.
36. Sadat-Ali M, Gullenpet AH, Al-Mulhim F, Al Turki H, Al-Shammary H, Al-Elq A et al.Osteoporosisrelated vertebral fractures in postmenopausal women: prevalence in a Saudi Arabian sample. East Mediterr Health J. 2009 Nov-Dec;15(6):1420-5.
37. Bubshait D, Sadat-Ali M. Economic implications of osteoporosis-related femoral fractures in Saudi Arabian society. Calcif Tissue Int. 2007 Dec;81(6):455-8. Epub 2007 Dec 4.
38. al-Nuaim AR, Kremli M, al-Nuaim M, Sandkgi S.Incidence of proximal femur fracture in an urbanized community in Saudi Arabia. Calcif Tissue Int. 1995 Jun;56(6):536-8.
39. World Health Organisation. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. WHO Technical report Series 843. Geneva: WHO, 1994.
40. Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997;12:1761-8.
41. Bilezikian JP. Osteoporosis in men. J Clin Endocrinol Metab 1999;84:3431-4.
42. Romagnoli E, Del Fiacco R, Russo S, Piemonte S, Fidanza F, Colapietro F, et al. Secondary Osteoporosis in Men and Women: Clinical Challenge of an Unresolved Issue. Rheumatol. 2011 Jun 1. [Epub ahead of print].
43. Brauer CA, Perraillon MC, Cutler DM, Rosen AB. "Incidence and mortality of hip fractures in the United States, " Journal of the American Medical Association 2009; 302 (14): 1573-79.
44. Balasegaram S, Majeed A, Fitz-Clarence H. Trends in hospital admissions for fractures of the hip and femur in England, 1989-1990 to 1997-1998. Journal of Public Health Medicine 2001; 23(1): 11-17.
45. Koh LKH, Saw SM, Lee JJM, Leong KH, Lee J. National Working Committee on Osteoporosis. Hip fracture incidence rates in Singapore 1991-1998. Osteoporosis International 2001; 12(4): 311-18.
46. Blake GM, Fogelman I. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J 2007; 83:509-17.
47. Writing Group for the ISCD Position Development Conference. Indications and reporting for dual-energy x-ray absorptiometry. J Clin Densitom 2004; 7:37-44.
48. Lewiecki EM, Binkley N, Petak SM. DXA quality matters. J Clin Densitom 2006; 9:388-92.
49. Sadat-Ali M, Al-Elq A, Al-Habdan IM, Al-Mohanna FA, Al-Mulhim AA. Quantitative ultrasound (QUS) of the os calcis in Saudi women: defining Saudi reference value for the diagnosis of low bone mass. Arch Osteoporos 2010; 5:139-144 DOI 10.1007/s11657-010-0047-3.
50. Hans D, Downs RW Jr, Duboeuf F, Greenspan S, Jankowski LG, Kiebzak GM, et al. Skeletal sites for osteoporosis diagnosis: the 2005 ISCD official positions. J Clin Densitom 2006; 9:15-21.
51. Hans D, Hartl F, Krieg MA. Device-specific weighted T-score for two quantitative ultrasounds: operational propositions for the management of osteoporosis for 65 years and older women in Switzerland. Osteoporos Int 2003; 14(3):251-258.
52. Clowes JA, Peel NF, Eastell R. Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice. Osteoporos Int 2006; 17(9):1293-1302.
53. Schott AM, Kassaï Koupaï B, Hans D, Dargent- Molina P, Ecochard R, Bauer DC et al. Should age influence the choice of quantitative bone assessment technique in elderly women? The EPI DOS study. Osteoporos Int 2004; 15(3):196-203.